{"meta":{"query_hash":"5e7fe4b0bbff","filters":{"venue":"Biologics in Therapy"},"cohort_total":1,"direct_labels_cover":0,"predictions_cover":1,"exported":1,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/5e7fe4b0bbff","api":"https://metacan.xera.ac/api/v1/cohort?venue=Biologics+in+Therapy"},"results":[{"id":"W2077733407","doi":"10.1007/s13554-011-0009-3","title":"New Frontiers in Subcutaneous Immunoglobulin Treatment","year":2011,"lang":"en","type":"review","venue":"Biologics in Therapy","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Multifocal motor neuropathy; Mismatch negativity; Intravenous Immunoglobulin Therapy; Tolerability; Adverse effect; Antibody; Internal medicine; Immunoglobulin G; Gastroenterology; Immunology","score_opus":0.0942810381799841,"score_gpt":0.3355394829311385,"score_spread":0.2412584447511544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077733407","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042032485,0.9960392,0.000014773188,0.000024186058,0.00074683473,0.0011548148,0.000013926921,0.000047750076,0.0015381821],"genre_scores_gemma":[0.000028449042,0.9970961,0.0012203366,0.00020362022,0.000107752385,0.000076032375,0.00008267582,0.00004224831,0.0011427753],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983767,0.00017607762,0.0005462566,0.00046470723,0.000066619985,0.0003695994],"domain_scores_gemma":[0.99926573,0.000046804067,0.0001615647,0.00042524986,0.000011444958,0.00008920184],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000109494635,0.00047742802,0.0018078011,0.00021824762,0.000019707453,0.000009876035,0.00021643956,0.0005045897,0.0002030041],"category_scores_gemma":[0.00002383965,0.0002875314,0.0004090266,0.00032693116,0.000057523408,0.000015350213,0.000025828525,0.0003288523,0.000028514312],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036930444,0.00022077747,0.0005822765,0.00023483901,0.000069786074,0.0004235397,0.00008549613,1.7404629e-7,0.0000012848795,0.000029780032,0.00084783905,0.9971349],"study_design_scores_gemma":[0.0013951411,0.0021187724,0.00008055923,0.0011397246,0.000044718145,0.000113315706,0.00003440348,7.408679e-7,7.822941e-7,0.00030831865,0.99448985,0.0002737002],"about_ca_topic_score_codex":0.0006059748,"about_ca_topic_score_gemma":0.000093112874,"teacher_disagreement_score":0.9968612,"about_ca_system_score_codex":0.0003224002,"about_ca_system_score_gemma":0.0003299212,"threshold_uncertainty_score":0.9999577},"labels":[],"label_agreement":null}]}